학술논문
532P - KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes?
Document Type
Abstract
Author
Source
In Annals of Oncology November 2018 29 Supplement 9:ix164-ix164
Subject
Language
ISSN
0923-7534